Dr. Aparna Kamat, MD
Claim this profileHouston Methodist Sugar Land Hospital
Area of expertise
Ovarian Cancer
Aparna Kamat, MD has run 5 trials for Ovarian Cancer. Some of their research focus areas include:
Fallopian Tube Cancer
Aparna Kamat, MD has run 2 trials for Fallopian Tube Cancer. Some of their research focus areas include:
Affiliated Hospitals
Houston Methodist Sugar Land Hospital
Methodist Willowbrook Hospital
Clinical Trials Aparna Kamat, MD is currently running
Avutometinib + Defactinib
for Ovarian Cancer
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (ICT) in subjects with recurrent LGSOC who have progressed on a prior platinum-based therapy.
Recruiting
2 awards
Phase 3
8 criteria
Herceptin Hylecta or Phesgo + Chemotherapy
for Uterine Cancer
This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta \[TM\]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesgo \[TM\]) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial cancer. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When trastuzumab or pertuzumab attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Hyaluronidase is an endoglycosidase. It helps to keep pertuzumab and trastuzumab in the body longer, so that these medications will have a greater effect. Hyaluronidase also allows trastuzumab and trastuzumab/pertuzumab to be given by injection under the skin and shortens their administration time compared to trastuzumab or pertuzumab alone. Paclitaxel is a taxane and in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Giving Herceptin Hylecta or Phesgo in combination with paclitaxel and carboplatin may shrink the tumor and prevent the cancer from coming back in patients with HER2 positive endometrial cancer.
Recruiting
2 awards
Phase 3
More about Aparna Kamat, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Aparna Kamat, MD has experience with
- Paclitaxel
- Afuresertib
- Ribociclib
- Letrozole
- InterVenn Ovarian Cancer Liquid Biopsy
- Defactinib
Breakdown of trials Aparna Kamat, MD has run
Ovarian Cancer
Fallopian Tube Cancer
Ovarian Adenocarcinoma
Ovarian Carcinoma
Peritoneal Serous Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Aparna Kamat, MD specialize in?
Aparna Kamat, MD focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are AKT positive.
Is Aparna Kamat, MD currently recruiting for clinical trials?
Yes, Aparna Kamat, MD is currently recruiting for 2 clinical trials in Sugar Land Texas. If you're interested in participating, you should apply.
Are there any treatments that Aparna Kamat, MD has studied deeply?
Yes, Aparna Kamat, MD has studied treatments such as Paclitaxel, Afuresertib, Ribociclib.
What is the best way to schedule an appointment with Aparna Kamat, MD?
Apply for one of the trials that Aparna Kamat, MD is conducting.
What is the office address of Aparna Kamat, MD?
The office of Aparna Kamat, MD is located at: Houston Methodist Sugar Land Hospital, Sugar Land, Texas 77479 United States. This is the address for their practice at the Houston Methodist Sugar Land Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.